ATE428931T1 - Verfahren zur durchführung von vollbluttests - Google Patents

Verfahren zur durchführung von vollbluttests

Info

Publication number
ATE428931T1
ATE428931T1 AT05759189T AT05759189T ATE428931T1 AT E428931 T1 ATE428931 T1 AT E428931T1 AT 05759189 T AT05759189 T AT 05759189T AT 05759189 T AT05759189 T AT 05759189T AT E428931 T1 ATE428931 T1 AT E428931T1
Authority
AT
Austria
Prior art keywords
whole blood
methods
disclosed
blood tests
performing whole
Prior art date
Application number
AT05759189T
Other languages
English (en)
Inventor
Mark Billadeau
Jeff Debad
Eli Glezer
Jonathan Leland
Charles Wijayawardhana
Original Assignee
Meso Scale Technologies Llc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Meso Scale Technologies Llc filed Critical Meso Scale Technologies Llc
Application granted granted Critical
Publication of ATE428931T1 publication Critical patent/ATE428931T1/de

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/52—Use of compounds or compositions for colorimetric, spectrophotometric or fluorometric investigation, e.g. use of reagent paper and including single- and multilayer analytical elements
    • G01N33/521—Single-layer analytical elements
    • G01N33/523—Single-layer analytical elements the element being adapted for a specific analyte
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
    • G01N33/54366—Apparatus specially adapted for solid-phase testing
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T436/00—Chemistry: analytical and immunological testing
    • Y10T436/10—Composition for standardization, calibration, simulation, stabilization, preparation or preservation; processes of use in preparation for chemical testing
    • Y10T436/106664—Blood serum or blood plasma standard or control
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T436/00—Chemistry: analytical and immunological testing
    • Y10T436/11—Automated chemical analysis
    • Y10T436/117497—Automated chemical analysis with a continuously flowing sample or carrier stream
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T436/00—Chemistry: analytical and immunological testing
    • Y10T436/25—Chemistry: analytical and immunological testing including sample preparation
    • Y10T436/25125—Digestion or removing interfering materials
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T436/00—Chemistry: analytical and immunological testing
    • Y10T436/25—Chemistry: analytical and immunological testing including sample preparation
    • Y10T436/25375—Liberation or purification of sample or separation of material from a sample [e.g., filtering, centrifuging, etc.]

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Molecular Biology (AREA)
  • Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Physics & Mathematics (AREA)
  • Microbiology (AREA)
  • Cell Biology (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Biotechnology (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Investigating Or Analysing Materials By The Use Of Chemical Reactions (AREA)
AT05759189T 2004-06-03 2005-06-03 Verfahren zur durchführung von vollbluttests ATE428931T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US57671004P 2004-06-03 2004-06-03
PCT/US2005/019498 WO2005121798A1 (en) 2004-06-03 2005-06-03 Methods and apparatuses for conducting assays

Publications (1)

Publication Number Publication Date
ATE428931T1 true ATE428931T1 (de) 2009-05-15

Family

ID=34982224

Family Applications (1)

Application Number Title Priority Date Filing Date
AT05759189T ATE428931T1 (de) 2004-06-03 2005-06-03 Verfahren zur durchführung von vollbluttests

Country Status (6)

Country Link
US (3) US7776583B2 (de)
EP (1) EP1766400B1 (de)
AT (1) ATE428931T1 (de)
DE (1) DE602005013957D1 (de)
DK (1) DK1766400T3 (de)
WO (1) WO2005121798A1 (de)

Families Citing this family (65)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PT1662987E (pt) * 2003-09-11 2012-02-14 Theranos Inc Dispositivo médico para monitorização de analito e distribuição de droga
EP1766400B1 (de) * 2004-06-03 2009-04-15 Meso Scale Technologies, LLC Verfahren zur durchführung von vollbluttests
US8617907B2 (en) * 2004-06-07 2013-12-31 Alere Switzerland Gmbh Determining the presence or amount of a metal-labelled species
CA2587945A1 (en) * 2004-11-17 2007-04-12 Bioveris Electrochemiluminescent assay
GB0503836D0 (en) * 2005-02-24 2005-04-06 Axis Shield Asa Method
MX2007013985A (es) * 2005-05-09 2008-02-22 Theranos Inc Sistemas de fluidos de punto de cuidado y usos de los mismos.
US20060275852A1 (en) * 2005-06-06 2006-12-07 Montagu Jean I Assays based on liquid flow over arrays
US11287421B2 (en) 2006-03-24 2022-03-29 Labrador Diagnostics Llc Systems and methods of sample processing and fluid control in a fluidic system
US8741230B2 (en) * 2006-03-24 2014-06-03 Theranos, Inc. Systems and methods of sample processing and fluid control in a fluidic system
US8007999B2 (en) 2006-05-10 2011-08-30 Theranos, Inc. Real-time detection of influenza virus
US20080113391A1 (en) 2006-11-14 2008-05-15 Ian Gibbons Detection and quantification of analytes in bodily fluids
CA2684221A1 (en) * 2007-04-12 2008-10-23 Regents Of The University Of Minnesota Systems and methods for analyzing a particulate
US20110189702A1 (en) * 2007-07-11 2011-08-04 Ya-Ping Sun Photoluminescent materials for multiphoton imaging
US8158430B1 (en) 2007-08-06 2012-04-17 Theranos, Inc. Systems and methods of fluidic sample processing
CA2701380C (en) * 2007-10-01 2014-03-11 University Of Southern California Detection of methylated dna and dna mutations
SE533515C2 (sv) * 2008-04-16 2010-10-12 Aamic Ab Analysförfarande för samtidig analys av flera analyter
US20100204062A1 (en) * 2008-11-07 2010-08-12 University Of Southern California Calibration methods for multiplexed sensor arrays
US20100135855A1 (en) * 2008-11-26 2010-06-03 Koninklijke Philips Electronics N.V. Method for depositing substances on a support
US20100256344A1 (en) * 2009-04-03 2010-10-07 University Of Southern California Surface modification of nanosensor platforms to increase sensitivity and reproducibility
AU2010308329B2 (en) 2009-10-19 2016-10-13 Labrador Diagnostics Llc Integrated health data capture and analysis system
WO2011062738A1 (en) 2009-11-23 2011-05-26 Mikhail Briman Controlled electrochemical activation of carbon-based electrodes
US20120309025A1 (en) * 2010-01-29 2012-12-06 Mochida Pharmaceutical Co., Ltd METHOD OF ANALYZING HUMAN sCD14-ST
US8236574B2 (en) 2010-03-01 2012-08-07 Quanterix Corporation Ultra-sensitive detection of molecules or particles using beads or other capture objects
WO2011109379A1 (en) 2010-03-01 2011-09-09 Quanterix Corporation Methods and systems for extending dynamic range in assays for the detection of molecules or particles
WO2011146881A1 (en) * 2010-05-20 2011-11-24 University Of Southern California Pan-antibody assays - principles, methods, and devices
WO2012051519A2 (en) 2010-10-14 2012-04-19 The Johns Hopkins University Biomarkers of brain injury
CA3177188A1 (en) 2011-01-06 2012-07-12 Meso Scale Technologies, Llc. Assay cartridges for pcr analysis and methods of use thereof
EP2527814A1 (de) * 2011-04-27 2012-11-28 Koninklijke Philips Electronics N.V. Sensorsystem mit austauschbarer Patrone und Lesegerät
EP2707389B1 (de) 2011-05-12 2019-10-30 The Johns Hopkins University Testreagenzien für eine neurogranin-diagnosekit
WO2013015822A1 (en) 2011-07-25 2013-01-31 Mikhail Briman Cartridge for diagnostic testing
SG11201404991YA (en) 2012-02-23 2014-09-26 Stage Cell Therapeutics Gmbh Chromatographic isolation of cells and other complex biological materials
US9625465B2 (en) 2012-05-15 2017-04-18 Defined Diagnostics, Llc Clinical diagnostic systems
US9081001B2 (en) 2012-05-15 2015-07-14 Wellstat Diagnostics, Llc Diagnostic systems and instruments
US9213043B2 (en) 2012-05-15 2015-12-15 Wellstat Diagnostics, Llc Clinical diagnostic system including instrument and cartridge
US20150025004A1 (en) * 2013-02-27 2015-01-22 Meso Scale Technologies, Llc Kidney function biomarkers
US9458488B2 (en) 2013-03-15 2016-10-04 Nanomix, Inc. Point of care sensor systems
EP3022322A4 (de) 2013-07-17 2017-05-17 The Johns Hopkins University Multiprotein-biomarkertest für den nachweis von hirnläsionen und ergebnis
RS62471B1 (sr) 2014-04-16 2021-11-30 Juno Therapeutics Gmbh Metode, kompleti i uređaji za proširenje populacije ćelija
IL292038B2 (en) 2014-04-23 2024-12-01 Juno Therapeutics Inc Methods for enriching or producing immune cell populations for adoptive therapy
US10222386B2 (en) 2014-09-19 2019-03-05 The Johns Hopkins University Biomarkers of congnitive dysfunction
EP3259594A4 (de) 2015-02-20 2018-12-26 The Johns Hopkins University Biomarker für myokardläsion
MA45489A (fr) 2015-10-22 2018-08-29 Juno Therapeutics Gmbh Procédés de culture de cellules, kits et appareil associés
KR102908806B1 (ko) 2015-10-22 2026-01-07 주노 테라퓨틱스 게엠베하 세포의 배양 방법 및 이를 위한 키트와 장치
RU2761555C2 (ru) 2015-10-22 2021-12-09 Джуно Терапьютикс Гмбх Способы, наборы, средства и устройства для трансдукции
US10088494B2 (en) * 2016-01-25 2018-10-02 Perkinelmer Health Sciences, Inc. Method and system for microfluidic sample analysis
US11143662B2 (en) 2016-06-30 2021-10-12 Brainbox Solutions, Inc. Circulating biomarker levels for diagnosis and risk-stratification of traumatic brain injury
AU2018260380B2 (en) 2017-04-27 2025-02-13 Juno Therapeutics Gmbh Oligomeric particle reagents and methods of use thereof
WO2018217792A1 (en) 2017-05-23 2018-11-29 Immunarray USA, Inc. Biomarker levels and neuroimaging for detecting, monitoring and treating brain injury or trauma
WO2019236632A1 (en) 2018-06-04 2019-12-12 Avon Products. Inc. Protein biomarkers for identifying and treating aging skin and skin conditions
BR112021002390A2 (pt) 2018-08-09 2021-05-11 Juno Therapeutics Inc processos para gerar células modificadas e suas composições
EP3853615B1 (de) * 2018-09-20 2024-01-17 Siemens Healthcare Diagnostics, Inc. Verfahren und vorrichtung zur hiln-bestimmung mit einem tiefen anpassungsnetzwerk für sowohl serum- als auch plasmaproben
MX2021003275A (es) * 2018-09-20 2021-04-28 Worcester Polytech Inst Metodos para capturar celulas con base en adherencia preferencial.
WO2020089343A1 (en) 2018-10-31 2020-05-07 Juno Therapeutics Gmbh Methods for selection and stimulation of cells and apparatus for same
CN120098057A (zh) 2019-03-01 2025-06-06 中尺度技术有限责任公司 用于免疫方法的被电化学发光标记的探针、使用这类探针的方法和包含这类探针的试剂盒
EP4143576A1 (de) 2020-05-01 2023-03-08 Meso Scale Technologies, LLC Serologische virusassays
US20240018571A1 (en) 2020-05-19 2024-01-18 Meso Scale Technologies, Llc. Methods, compositions, and kits for nucleic acid detection
WO2022072479A1 (en) 2020-09-29 2022-04-07 The Johns Hopkins University Integrated proteomic biomarkers for the detection of aggressive prostate cancer
WO2022221660A1 (en) 2021-04-16 2022-10-20 Meso Scale Technologies, Llc. Methods, compositions, and kits for detecting hydrolase enzyme activity
WO2022246215A1 (en) 2021-05-21 2022-11-24 Meso Scale Technologies, Llc. Viral strain serology assays
AU2022304570A1 (en) 2021-06-28 2024-01-18 Meso Scale Technologies, Llc. Methods, compositions, and kits for assay signal amplification
CA3240519A1 (en) 2021-12-10 2023-06-15 The Johns Hopkins University Biomarkers to detect aggressive prostate cancer from indolent forms and treatment thereof
EP4540610A1 (de) 2022-06-17 2025-04-23 Meso Scale Technologies, LLC Serologische tests für virenstämme
EP4591062A1 (de) 2022-09-23 2025-07-30 Meso Scale Technologies, LLC Serologietests für orthopoxvirus
AU2023408595A1 (en) 2022-12-20 2025-07-17 Meso Scale Technologies, Llc. Assay methods and kits
WO2025049305A1 (en) 2023-08-25 2025-03-06 Meso Scale Technologies, Llc. Viral strain serology assays

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE388694B (sv) * 1975-01-27 1976-10-11 Kabi Ab Sett att pavisa ett antigen exv i prov av kroppvetskor, med utnyttjande av till porost berarmaterial bundna eller adsorberande antikroppar
US4235601A (en) * 1979-01-12 1980-11-25 Thyroid Diagnostics, Inc. Test device and method for its use
US4366241A (en) * 1980-08-07 1982-12-28 Syva Company Concentrating zone method in heterogeneous immunoassays
US4442204A (en) * 1981-04-10 1984-04-10 Miles Laboratories, Inc. Homogeneous specific binding assay device and preformed complex method
US5208535A (en) * 1990-12-28 1993-05-04 Research Development Corporation Of Japan Mr position detecting device
US5460945A (en) * 1991-05-30 1995-10-24 Center For Blood Research, Inc. Device and method for analysis of blood components and identifying inhibitors and promoters of the inflammatory response
SE9401102D0 (sv) * 1994-03-31 1994-03-31 Pharmacia Biosensor Ab Assay method
EP0905514B1 (de) * 1997-09-27 2003-11-26 Horiba, Ltd. Gerät für die Zählung von Blutzellen und zur immunologischen Bestimmung unter Verwendung von Vollblut
US6475372B1 (en) * 2000-02-02 2002-11-05 Lifescan, Inc. Electrochemical methods and devices for use in the determination of hematocrit corrected analyte concentrations
US6383748B1 (en) * 1999-09-14 2002-05-07 Pamgene B.V. Analytical test device with substrate having oriented through going channels and improved methods and apparatus for using same
EP1583950B1 (de) * 2002-12-26 2017-04-05 Meso Scale Technologies, LLC. Testkassetten und verfahren zu ihrer verwendung
EP1766400B1 (de) * 2004-06-03 2009-04-15 Meso Scale Technologies, LLC Verfahren zur durchführung von vollbluttests

Also Published As

Publication number Publication date
US20060019319A1 (en) 2006-01-26
DK1766400T3 (da) 2009-07-20
WO2005121798A1 (en) 2005-12-22
US7776583B2 (en) 2010-08-17
US20100267063A1 (en) 2010-10-21
EP1766400B1 (de) 2009-04-15
US8273566B2 (en) 2012-09-25
US8343526B2 (en) 2013-01-01
EP1766400A1 (de) 2007-03-28
DE602005013957D1 (de) 2009-05-28
US20120034645A1 (en) 2012-02-09

Similar Documents

Publication Publication Date Title
DE602005013957D1 (de) Verfahren zur durchführung von vollbluttests
DE502004008216D1 (de) Vorrichtung und verfahren zur simultanen durchführung von blutgruppenbestimmung, serumgegenprobe und antikörpersuch-test
SE0303249D0 (sv) Hematocrit and analyte concentration determination
WO2004011607A3 (en) Reagent and method for determination of a substance using an immunoaggregator
ATE554168T1 (de) Integriertes mikrofluidisches bauteil zum aufreinigen von analytmolekülen sowie verfahren zum aufreinigen
CY1117282T1 (el) Διαταξη και μεθοδος ανιχνευσεως προσδιοριζομενων ουσιων
ATE553216T1 (de) Sonden, bibliotheken und kits zur analyse von nukleinsäuregemischen und verfahren zu deren konstruktion
ATE278771T1 (de) Vorrichtung und verfahren zur analyse flüssiger proben
ATE541054T1 (de) Bio-barcode erkennung für zielmoleküle
ATE431854T1 (de) Auf bio-barcodes beruhender nachweis von zielanalyten
ATE428929T1 (de) Reagens, ausstattung und verfahren zur probenanalyse
ATE510931T1 (de) Materialien und verfahren zur erfassung von pathogenen und entfernung von aurin- tricarbonsäure aus einer probe
MX369610B (es) Metodos, dispositivos y sistemas para analisis de muestras.
ATE408829T1 (de) Verfahren und assaykits zum nachweis mononuklearer zellphänotypen
DE502005004800D1 (de) Vorrichtung und verfahren zum nachweis von analyten durch sichtbarmachung und separation von agglutination
WO2002042500A3 (en) Apparatus and method for electrophoretic microspot concentration
DE602005015299D1 (de) Verfahren, chip, vorrichtung und integriertes system zum nachweis biologischer partikel
WO2005024384A3 (en) Devices and methods for separating phospholipids from biological samples
ATE421095T1 (de) Porosität und biologische aktivität beibehaltende haftmembranen in einer assay-einrichtung zur messung von serum cholesterin in assoziation mit hochdichten lipoproteinen
ATE378591T1 (de) Verfahren und vorrichtung zur vorhersage von kardiovaskulären ereignissen
EP3736571A4 (de) Verfahren, reagenz und chip zur messung der analytkonzentration in einer biologischen probe
ATE416384T1 (de) Verfahren und kit zum quantitativen und/oder qualitativen nachweis von komponenten in einer probe
DE60219642D1 (de) Bestimung und quantifizierung von erythrocytenpopulationen in proben
WO2006051548A3 (en) Blood type method system and device
ATE405592T1 (de) Verfahren zur bildung eines protein- mikroarraysystems

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties